Wellcome Sanger Institute
Sanger Institute Science Collaboration

UK Inflammatory Bowel Disease Genetics Consortium

The UKIBD Genetics Consortium (UKIBDGC) comprises clinicians and scientists with a track record of successful collaborative research in the genetics of inflammatory bowel disease. Our aims are to identify and understand the genes that determine disease susceptibility, course and response and side effects of treatment. The UKIBDGC is a major contributor to the International IBD Genetics Consortium.


If you need help or have any queries, please contact us using the details below.

Sanger people

Photo of Dr Carl Anderson

Dr Carl Anderson

Head of Human Genetics and Senior Group Leader